Ryan Walter Hick, MD, FAAD
SESSIONS
F091 Navigating Prior Authorization in Dermatology: Challenges, Innovations, and Solutions
Mar 10, 2025
•
1:00 PM - 3:00 PM
•
W202C
DISCLOSURES
AbbVie – Stockholder(No Compensation Received); Gilead Sciences – Stockholder(No Compensation Received); Merck & Co., Inc – Stockholder(No Compensation Received); Pfizer Inc. – Stockholder(No Compensation Received); PP Capital – Stockholder(No Compensation Received); Sonic Healthcare – Stockholder(No Compensation Received); Stingray Therapeutics – Stockholder(No Compensation Received);